10-K: Oaktree Acquisition Corp. III Life Sciences Details Security Structure in 10-K Filing

Oaktree Acquisition Corp. III Life Sciences outlines the terms and conditions of its securities, including ordinary shares, warrants, and units, in its latest 10-K filing.

Summary

• Oaktree Acquisition Corp. III Life Sciences, a Cayman Islands exempted company, details the terms of its securities in its 10-K filing.
• The company is authorized to issue 300,000,000 Class A ordinary shares, 30,000,000 Class B ordinary shares, and 1,000,000 preference shares.
• Each unit in the initial public offering was priced at $10.00 and consists of one Class A ordinary share and one-fifth of one redeemable warrant.
• Each whole warrant allows the holder to purchase one Class A ordinary share at $11.50, subject to adjustments.
• As of the IPO closing, there were 24,582,768 ordinary shares outstanding, including 19,199,029 Class A shares, 583,981 private placement shares, and 4,799,758 Class B shares held by the sponsor.
• Ordinary shareholders are entitled to one vote per share, with Class A and Class B shares voting together, except as required by law.
• The company will provide public shareholders the opportunity to redeem their public shares upon completion of an initial business combination at a cash price per share equal to the aggregate amount in the trust account, initially anticipated to be $10.00 per share.
• If an initial business combination is not completed within 24 months from the IPO, the company will redeem public shares at a per-share price equal to the amount in the trust account, liquidate, and dissolve.
• The sponsor has agreed to waive their rights to liquidating distributions from the trust account with respect to any founder shares or private placement shares if an initial business combination is not completed within 24 months.
• Up to $1,500,000 of loans from the sponsor or its affiliates may be convertible into private placement units at $10.00 per unit.
• The company has adopted an insider trading policy to promote compliance with securities laws.

Sentiment

Score: 6

Explanation: The document is factual and descriptive, outlining the company's structure and operations. While it highlights potential risks, it also presents positive aspects like redemption rights and the sponsor's commitment.

Positives

• Public shareholders have the right to redeem their shares for cash upon completion of the initial business combination.
• The sponsor has agreed to waive their rights to liquidating distributions from the trust account if a business combination is not completed within 24 months.
• The company has implemented a clawback policy to recoup executive compensation in the event of an accounting restatement.
• The company has established an insider trading policy to promote compliance with securities laws.

Negatives

• If an initial business combination is not completed within 24 months, the warrants will expire worthless.
• The sponsor may be incentivized to complete a transaction even if it is not in the best interest of public shareholders.
• The company's reliance on a small management team and their other commitments could create conflicts of interest.
• The company's indemnification obligations may discourage shareholders from bringing lawsuits against officers or directors.

Risks

• The company may not be able to complete an initial business combination within 24 months.
• The company may be deemed an investment company under the Investment Company Act.
• The company may face difficulties in enforcing legal rights due to its incorporation in the Cayman Islands.
• The company's reliance on a small management team and their other commitments could create conflicts of interest.
• The company's indemnification obligations may discourage shareholders from bringing lawsuits against officers or directors.
• The company may be affected by numerous risks inherent in the business operations with which it combines.
• The company may be unable to obtain additional financing to complete its initial business combination or to fund the operations and growth of a target business.

Future Outlook

The company intends to focus on opportunities in the healthcare or healthcare-related industries in North America, the United Kingdom and Western Europe.

Industry Context

The healthcare sector has seen continuous innovation and rapid technological advancements over the last decade, making it one of the fastest-growing industries.

Comparison to Industry Standards

• Oaktree has a stellar special purpose acquisition company (SPAC) track record, specifically in the healthcare space with two prior de-SPACing acquisitions of Hims & Hers Health, Inc. (NYSE:HIMS) and Alvotech (NASDAQ:ALVO).
• As of December 31, 2024, across both transactions Oaktrees SPACs had generated a combined equity return of approximately 102% since their respective IPOs.

Corporate Governance

Related Party Transactions

• The company pays the sponsor $25,000 per month for office space, secretarial, and administrative services.
• The sponsor may loan the company funds for working capital or transaction costs, up to $1,500,000 of which may be convertible into private placement units.
• The company has agreed to indemnify the sponsor and its affiliates from certain liabilities.

Stakeholder Impact

• Public shareholders have the opportunity to redeem their shares upon completion of a business combination.
• The sponsor has agreed to waive their rights to liquidating distributions from the trust account with respect to founder shares and private placement shares if a business combination is not completed within 24 months.
• The company's success depends on the performance of a single business after the initial business combination.

Next Steps

• The company intends to identify and evaluate suitable targets for a business combination.
• The company will conduct due diligence on prospective target businesses.
• The company will structure and negotiate the terms of a business combination transaction.

Key Dates

Keywords

business combination, ordinary shares, warrants, redemption rights, trust account, sponsor, initial public offering, securities, private placement, liquidation